Category:Drugs: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
No edit summary
Helen (talk | contribs)
No edit summary
Line 10: Line 10:
*[[:Category: Calcium-channel Blocker, CCB | Calcium-channel Blocker, CCB]]
*[[:Category: Calcium-channel Blocker, CCB | Calcium-channel Blocker, CCB]]
*[[:Category: Diuretics | Diuretics]]
*[[:Category: Diuretics | Diuretics]]
</div>
</div>
|}
{|
|<div class="toccolours mw-collapsible mw-collapsed">[[:Category:Antiplatelet drugs | Antiplatelet drugs]]
<div class="mw-collapsible-content">
Platelet aggregation is important in haemostasis  and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.
Antiplatelet drugs act through a wide range of mechanisms. Aspirin  is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.


</div>
</div>
</div>
</div>
|}
|}

Revision as of 03:52, 5 August 2022

Cardiovascular Drug

Although very diverse, cardiovascular drugs can be broadly classified according to their pharmacological action. Basic details of the major groups, together with lists of the drugs are described as follow:


Antiplatelet drugs

Platelet aggregation is important in haemostasis and is also involved in thrombus formation, particularly in the arterial circulation. Antiplatelet drugs reduce platelet aggregation and are used to prevent further thromboembolic events in patients who have suffered myocardial infarction, ischaemic stroke or transient ischaemic attacks, or unstable angina, and for primary prevention of a thromboembolic event in patients at risk.

Antiplatelet drugs act through a wide range of mechanisms. Aspirin is the most widely used. It acts by irreversibly inhibiting platelet cyclo-oxygenase and thus preventing synthesis of thromboxane A2.

Pages in category "Drugs"

The following 200 pages are in this category, out of 295 total.

(previous page) (next page)
(previous page) (next page)